BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 31618801)

  • 1. Positive correlation between pancreatic volume and post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Maruyama H; Shiba M; Ishikawa-Kakiya Y; Kato K; Ominami M; Fukunaga S; Otani K; Hosomi S; Tanaka F; Kamata N; Taira K; Nagami Y; Yamagami H; Tanigawa T; Watanabe T; Yamamoto A; Kabata D; Shintani A; Fujiwara Y
    J Gastroenterol Hepatol; 2020 May; 35(5):769-776. PubMed ID: 31618801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of pancreatic volume quantitative analysis as a predictor of development and severity in post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Akazawa Y; Ohtani M; Nosaka T; Takahashi K; Naito T; Matsuda H; Nakamoto Y
    Pancreatology; 2024 Jun; ():. PubMed ID: 38879434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM; Abraham O; Huang R; Barth BA
    Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pancreatic stents for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis should be inserted up to the pancreatic body or tail.
    Sugimoto M; Takagi T; Suzuki R; Konno N; Asama H; Sato Y; Irie H; Watanabe K; Nakamura J; Kikuchi H; Waragai Y; Takasumi M; Hikichi T; Ohira H
    World J Gastroenterol; 2018 Jun; 24(22):2392-2399. PubMed ID: 29904246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre- and post-procedure risk prediction models for post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Park CH; Park SW; Yang MJ; Moon SH; Park DH
    Surg Endosc; 2022 Mar; 36(3):2052-2061. PubMed ID: 34231067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of pancreatitis after endoscopic retrograde cholangiopancreatography in patients with biliary tract diseases.
    Chi JY; Ma LY; Zou JC; Ma YF
    BMC Surg; 2023 Mar; 23(1):62. PubMed ID: 36959589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for postendoscopic retrograde cholangiopancreatography pancreatitis: a retrospective analysis of 7,168 cases.
    Zhou W; Li Y; Zhang Q; Li X; Meng W; Zhang L; Zhang H; Zhu K; Zhu X
    Pancreatology; 2011; 11(4):399-405. PubMed ID: 21894057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Post-Endoscopic Retrograde Pancreatography Pancreatitis: A Retrospective Chart Review in a Regional Hospital in Japan.
    Shimamura T; Miyahara K; Takamori A; Hidaka H; Ito Y; Fujimoto S; Takedomi H; Tsuruoka N; Sakata Y; Eguchi Y; Node K; Noda T; Fujimoto K
    Digestion; 2020; 101(5):557-562. PubMed ID: 31487723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prophylactic stents in the prevention of pancreatitis following endoscopic retrograde cholangiopancreatography].
    Dubravcsik Z; Hritz I; Szepes A; Madácsy L
    Orv Hetil; 2021 Jan; 162(1):31-38. PubMed ID: 33388737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency of Post Endoscopic Retrograde Cholangiopancreatography Acute Pancreatitis in an Academic Hospital of Bangladesh.
    Islam MS; Khalil MM; Hossain MI; Datta RK; Podder S; Khan ST; Ahmed F; Ahmed F; Rahman MM; Kibria MG
    Mymensingh Med J; 2024 Jan; 33(1):133-139. PubMed ID: 38163784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors of post- endoscopic retrograde cholangiopancreatography pancreatitis in biliary type sphincter of Oddi dysfunction in Japanese patients.
    Miyatani H; Matsumoto S; Mashima H
    J Dig Dis; 2017 Oct; 18(10):591-597. PubMed ID: 28898571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the most adapted indication of prophylactic pancreatic duct stent within the high-risk group of post-endoscopic retrograde cholangiopancreatography pancreatitis? Using the propensity score analysis.
    Takenaka M; Fujita T; Sugiyama D; Masuda A; Shiomi H; Sugimoto M; Sanuki T; Hayakumo T; Azuma T; Kutsumi H
    J Hepatobiliary Pancreat Sci; 2014 Apr; 21(4):275-80. PubMed ID: 24039185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between papilla-related variables and post endoscopic retrograde cholangiopancreatography pancreatitis: A multicenter, prospective study.
    Wang X; Zhao J; Wang L; Ning B; Zeng W; Tao Q; Ren G; Liang S; Luo H; Wang B; Farrell JJ; Pan Y; Guo X; Wu K
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2184-2191. PubMed ID: 32511794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal Indomethacin Reduces Pancreatitis in High- and Low-Risk Patients Undergoing Endoscopic Retrograde Cholangiopancreatography.
    Thiruvengadam NR; Forde KA; Ma GK; Ahmad N; Chandrasekhara V; Ginsberg GG; Ho IK; Jaffe D; Panganamamula KV; Kochman ML
    Gastroenterology; 2016 Aug; 151(2):288-297.e4. PubMed ID: 27215656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-endoscopic retrograde cholangiopancreatography pancreatitis: A systematic review for prevention and treatment.
    Pekgöz M
    World J Gastroenterol; 2019 Aug; 25(29):4019-4042. PubMed ID: 31413535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nafamostat Mesylate is Not Effective in Preventing Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis.
    Matsumoto T; Okuwaki K; Imaizumi H; Kida M; Iwai T; Yamauchi H; Kaneko T; Hasegawa R; Masutani H; Tadehara M; Adachi K; Watanabe M; Kurosu T; Tamaki A; Kikuchi H; Ohno T; Koizumi W
    Dig Dis Sci; 2021 Dec; 66(12):4475-4484. PubMed ID: 33495919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pancreatic fat on the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Park CH; Chung MJ; Park DH; Min S; Park SW
    Surg Endosc; 2022 Aug; 36(8):5734-5742. PubMed ID: 35099627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of fully covered metal stenting on the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis: A large multicenter study·.
    Xia MX; Zhou YF; Zhang M; Wang W; Wu J; Wang TT; Zhang XF; Hu B
    J Gastroenterol Hepatol; 2020 Dec; 35(12):2256-2263. PubMed ID: 32473034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.